AI TOOL PROFILE

DrugPatentWatch: Pharmaceutical Patent Intelligence Software

DrugPatentWatch helps pharmaceutical companies and legal professionals track patent expirations and generic entry. It is designed for teams that need to monitor loss-of-exclusivity dates and competitive landscapes.

Pricing

Subscription plans start at $1,000 per month for the Starter tier. The Professional tier is $3,000 per month and includes AI features, while Enterprise pricing is custom. A limited one-month all-access offer is available for $499 until April 8th, 2026.

At a glance

Best for
Pharmaceutical companies, Biotech companies, Law firms, Pharmaceutical researchers, Business intelligence teams
Key use cases
Identifying Generic Entry Opportunities, Biosimilar Activity Monitoring, Competitive Intelligence, Supply Chain Sourcing, Market-Entry Strategy
Integrations
Data export (Professional/Enterprise plans)
Visit drugpatentwatchdrugpatentwatch software interface screenshot

How AI is used

DrugPatentWatch is a business intelligence platform for the biopharmaceutical sector. It provides a database of active and expired patents for small-molecule drugs in 134 countries, which helps users monitor regulatory protections and exclusivity statuses.

The tool is designed for pharmaceutical and biotech companies, law firms, and researchers. It supports workflows related to drug lifecycle management by tracking patent challenges, tentative approvals, and the entry of generic and biosimilar competitors.

In addition to database access, the platform includes an AI Research Assistant and a Deep Research Engine to answer queries. Users can also access drug sales data, pricing information, and litigation histories to help inform market-entry strategies.

Buyers should confirm their specific needs regarding subscription tiers, as the Starter plan has limits on searches and does not support data export, while AI features are available in higher-tier plans.

Key Features

  • Global Patent Tracking

    Provides data on active and expired patents across 134 countries.

  • Loss-of-Exclusivity Monitoring

    Tracks exclusivity expiration dates, Paragraph IV challenges, and tentative approvals.

  • AI Research Assistant

    Provides cited answers to queries that may extend beyond the primary database scope.

  • Deep Research Engine

    Designed to aggregate information from disparate sources for in-depth analysis.

  • Market Data Access

    Includes drug sales figures, brand versus generic price gaps, and annual gross revenues.

  • Litigation Tracking

    Monitors US District Court cases and Patent Trial and Appeal Board (PTAB) reviews.

  • Automated Reports and Custom Dashboards

    Supports the automation of reporting processes to help reduce manual workload.

Use Cases

  • Identifying Generic Entry Opportunities

    Monitoring patent expirations and loss-of-exclusivity dates to identify when generic versions of a drug may enter the market.

  • Biosimilar Activity Monitoring

    Tracking the development and clinical trial progress of biosimilars and 505(b)(2) drug pathways.

  • Competitive Intelligence

    Analyzing competitor NDAs, patents, and litigation history to help anticipate market moves.

  • Supply Chain Sourcing

    Identifying API vendors and finished product suppliers for specific drug ingredients.

  • Market-Entry Strategy

    Using historical sales and price range data to evaluate market potential and help set launch prices.

Integrations

  • Data export (Professional/Enterprise plans)

FAQ

What data does DrugPatentWatch provide?

It provides data on active and expired drug patents in 134 countries, including loss-of-exclusivity dates, drug sales, pricing, and litigation information.

Who is the target user for this platform?

The platform is designed for pharmaceutical and biotech companies, legal professionals, researchers, and business intelligence teams.

Does DrugPatentWatch use AI?

Yes, it includes an AI Research Assistant and a Deep Research Engine to help users find cited answers to queries beyond the primary database.

Which plan is best for users who need to export data?

Buyers needing data export capabilities should consider the Professional or Enterprise plans, as the Starter tier does not support data export.

Source category: Data & Analytics

Source subcategory: Business Intelligence

More tools in Data & Analytics

Other published listings in the Data & Analytics category.

Browse all tools in Data & Analytics

More tools in the Business Intelligence software type

Related listings that share the same software type for comparison and shortlisting.

Browse all Business Intelligence software type tools